| Cat.No. | Name | Information |
|---|---|---|
| M14360 | Copper tripeptide | Copper tripeptide (GHK-Cu), a naturally occurring tripeptide, is first isolated from human plasma, but can be found in saliva and urine. |
| M14157 | D-JNKI-1 | D-JNKI-1 (AM-111) is a highly potent and cell-permeable peptide inhibitor of JNK. |
| M14067 | Argipressin | Argipressin (Arg8-vasopressin) binds to the V1, V2, V3-vascular arginine vasopressin receptor, with a Kd value of 1.31 nM in A7r5 rat aortic smooth muscle cells for V1. |
| M14063 | Pasireotide acetate | Pasireotide (SOM230) acetate, a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). |
| M14062 | Octreotide | Octreotide is a somatostatin analog that binds to the somatostatin receptor, mainly subtypes 2, 3, and 5, increases Gi activity, and reduces intracellular cAMP production. |
| M13970 | Lixisenatide acetate | Lixisenatide acetate is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). |
| M13957 | Carperitide acetate | Carperitide acetate (Atrial Natriuretic Peptide (ANP) (1-28), human, porcine acetate) is a 28-amino acid hormone, that is normally produced and secreted by the human heart in response to cardiac injury and mechanical stretch. |
| M13916 | Icatibant | Icatibant (HOE-140) is a potent and specific peptide antagonist of bradykinin B2 receptor with IC50 and Ki of 1.07 nM and 0.798 nM respectively. |
| M13906 | Angiotensin II human TFA | Angiotensin II human (Angiotensin II) TFA is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system. |
| M13905 | Angiotensin II human acetate | Angiotensin II human (Angiotensin II) acetate is a vasoconstrictor and a major bioactive peptide of the renin/angiotensin system. |
| M13904 | Angiotensin (1-7) (acetate) | Angiotensin 1-7 (Ang-(1-7)) acetate is an endogenous heptapeptide from the renin-angiotensin system (RAS) with a cardioprotective role due to its anti-inflammatory and anti-fibrotic activities in cardiac cells. |
| M13486 | Enfuvirtide | Enfuvirtide (T20; DP178) is an anti-HIV-1 fusion inhibitor peptide. |
| M13445 | Peripheral Myelin P0 Protein (180-199), mouse | Peripheral Myelin P0 Protein (180-199), mouse is a neurogenic peptide purified from Peripheral Myelin of mice. Sequence：Ser-Ser-Lys-Arg-Gly-Arg-Gln-Thr-Pro-Val-Leu-Tyr-Ala-Met-Leu-Asp-His-Ser-Arg-Ser |
| M13376 | Abarelix | Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer. Sequence：Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2 |
| M13375 | Cetrorelix Acetate | Cetrorelix Acetate (SB-75 acetate) is a potent gonadotropin-releasing hormone (GnRH) receptor antagonist with an IC50 of 1.21 nM. Sequence：Ac-D2Nal-D4Cpa-D3Pal-Ser-Tyr-DCit-Leu-Arg-Pro-DAla-NH2 |
| M13374 | Ganirelix | Sequence: Ac-D-2-Nal-D-Phe(4-Cl)-D-3-Pal-Ser-Tyr-D-Lys(C(NHEt)2)-Leu-Lys(C(NHEt)2)-Pro-D-Ala-NH2 |
| M13354 | Angiopep-2 TFA | Angiopep-2 TFA is a brain peptide carrier. Binding of the antitumor compound to angiopEP-2 peptide carrier enhances its activity in brain cancer. Amino acid serial sequence: Thr-Phe-Phe-Tyr- GLly - Glly -Ser-Arg- GLly -Lys-Arg-Asn-Asn-Phe-Lys-Thr- glu-glu-TYr |
| M11506 | Ovalbumin (323-339) (chicken, japanese quail) | OVA Peptide (323-339) is an MHC Class II (H-2B) restricted OVA Peptide epitope that binds to the L-A (D) region of Class II MHC protein. It is widely used to study the natural properties of Class II MHC peptide binding and the mechanism of T cell activation. It is also commonly used to study immune allergic reactions, including asthma and food allergies. |
| M11457 | Desmopressin Acetate | Desmopressin is a synthetic octapeptide that is an analogue of the human hormone arginine vasopressin and has antidiuretic and procoagulant effects. |
| M11438 | Zilucoplan | Zilucoplan is a 15 amino acid macrocyclic peptide and potent complement component 5 (C5) inhibitor that specifically targets C5, a component of the terminal complement activation pathway, thereby preventing the cleavage of C5 by C5 converting enzyme into complement components C5a and C5b, and thus preventing the downstream assembly and activity of the membrane attack complex (MAC). Can be used in studies related to immune-mediated necrotizing myopathy (IMNM) and generalized myasthenia gravis (gMG). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
